National
N.J. Senate kills marriage legislation
The New Jersey State Senate on Thursday defeated legislation that would have legalized same-sex marriage in the Garden State, but plans are already brewing to obtain marriage rights for gay couples through litigation.
Senators voted down the measure, 14-20, following a 90-minute debate. After the vote was recorded, opponents of gay nuptials filled the Senate chamber with cheers and applause.
The bill’s failure almost certainly means New Jersey won’t see the legalization of same-sex marriage through legislative means anytime soon. Republican Governor-elect Chris Christie will begin his four-year term Jan. 19, and he’s pledged to veto any marriage bill that comes to his desk.
Outgoing Gov. Jon Corzine (D) in a statement Thursday expressed disappointment about the outcome of the vote, although he commended the Senate for having public debate on the issue.
“Most assuredly, this is an issue of civil rights and civil liberties, the foundation of our state and federal constitutions,” he said. “Denying any group of people a fundamental human right because of who they are, or whom they love, is wrong, plain and simple.”
Celebrating the victory was the National Organization for Marriage. In an e-mail blast, Brian Brown, the organization’s executive director, praised followers who “made phone calls, sent e-mails, and prayed” in opposition to same-sex marriage.
“Yet again, we have witnessed a tremendous victory for marriage in a state where just a few months ago, victory seemed unlikely at best,” he said.
Immediately following the vote, Kevin Cathcart, executive director of Lambda Legal, announced in a statement plans to pursue the legalization of same-sex marriage in New Jersey through court action.
“The requirement to ensure equality for same-sex couples, established by the New Jersey Supreme Court in its decision in our marriage lawsuit in 2006, has not been met,” he said. “There is enormous, heartbreaking evidence that civil unions are not equal to marriage, and we will be going back to the courts in New Jersey to fight for equality.”
New Jersey won’t ‘go all the way backwards’
In a conference call following the vote, Steven Goldstein, chair of Garden State Equality, said advocates of same-sex marriage have had “a seamless transition from our legislative phase to our court phase.”
“It’s not a situation where New Jersey will go all the way backwards,” he said. “In New Jersey, the Supreme Court ruled in 2006 that same-sex couples must receive equal treatment under the law as a state constitutional matter.”
Goldstein said he didn’t yet know details about the litigation, such as who would become plaintiff couples or when the New Jersey Supreme Court would hear the case.
Reflecting on the vote, Goldstein said the marriage bill didn’t succeed for one reason: the failure of Corzine to win re-election in November.
“We had at minimum 22 votes in the Senate … and we were going to win this clearly in the Assembly,” he said. “At some point immediately after the election, we saw the fortunes change.”
Goldstein said Corzine was “a star supporter of marriage equality” throughout most of 2009, but added “it did take him a while to get there.”
“We were very honest in our statement today in saying that this bill should never have waited until sudden death overtime — the lame duck session,” he said. “And obviously we’re disappointed in that.”
Opposition to the bill also increased, Goldstein said, because Christie visited Republican senators before the debate and urged them to vote against the legislation.
“We understand from impeccable sources that Governor-elect Christie went to the Republican Senate caucus and in the Republican Assembly caucus and told members who were going to vote for marriage equality, ‘I don’t want to see any marriage equality votes coming out of this caucus,’” Goldstein said.
Even though they thought they might not win, Goldstein said advocates held the vote in the Senate because they believed it would bolster the chances of litigation.
“We consulted and spoke with lawyers far and wide who said the New Jersey Legislature has to show its dereliction of duty affirmatively to go back to court — because they said it’s up to the Legislature to act,” he said. “Today the Legislature acted. It defaulted on its constitutional obligation to provide same-sex couples equality.”
Noting that a number of lawmakers who voted against the marriage bill also conceded on the floor civil unions aren’t working, Goldstein said the Senate record will also help persuade the courts that civil unions aren’t adequate in providing protections for same-sex couples.
Passionate flare on Senate floor
Several senators gave emotional speeches on both sides of the marriage issue on the Senate floor before the vote was taken. State Sen. Loretta Weinberg, a Democrat and sponsor of the marriage legislation, was among those who spoke in favor of the bill.
“Men and women do not have a monopoly on loving relationships,” she said. “We all know same-sex couples that enjoy the same love and trust that is shared between a man and a woman, between a husband and a wife.”
Also speaking out in favor of the legislation was State Sen. Raymond Lesniak, another Democrat who sponsored the bill.
Noting that 120 religious leaders sent a letter to the New Jersey Senate in support of same-sex marriage, Lesniak said the failure of the chamber to pass the legislation would amount to religious discrimination.
“Unless we vote for marriage equality, we will be interfering with the religious beliefs of many of our citizens,” he said. “Government is wrong to interfere with religious beliefs. Today, we can right that wrong.”
State Sen. Bill Baroni, the lone Republican to vote in favor of the marriage legislation, said New Jersey’s current system of offering civil unions to same-sex couples amounted to discrimination perpetuated by the government.
“Government says [these couples] are different and segregates from the married couples, and that is textbook, old-fashioned discrimination — where government looks at people and discriminates against them,” he said.
Equally emotional were speeches against same-sex marriage. State Sen. Michael Doherty, a Republican, criticized the process that advocates had chosen to legalize same-sex marriage and called instead for a referendum on the issue.
“Suddenly today, you’re somehow crazy if you want the people of New Jersey to decide this issue like they have in 31 other states,” he said. “This is about the process; this is about letting the residents of New Jersey decide a major redefinition that has been recognized for thousands and thousands of years.”
Also opposed to the legislation was State Sen. Sean Kean, another Republican who said he voted against same-sex marriage even though he had “the gayest senate district in New Jersey” because it has a significant number of LGBT residents.
“Guess … to those proponents of this bill that I am unfortunately going to disagree with today,” he said. “Sometimes people just disagree with you. Maybe they don’t share your perspective, maybe they don’t share your values, maybe they just disagree with you.”
One senator who spoke in favor of the marriage bill and gave a particularly well-received speech among advocates was State Sen. Nia Gill. A black woman, Gill compared to lack of marriage rights for gay couples to previous laws forbidding interracial marriage and suffrage for women.
“This body cannot advocate its responsibility,” she said. “Once we have taken state action, that state action must be constitutional in its protection.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
